Stempoint Capital »

Argenx Se shares owned by Stempoint Capital

Quarter-by-quarter ownership of Argenx Se (ARGX) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Argenx Se

Tip: Access up to 7 years of quarterly data

All positions including Argenx Se held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Argenx Se by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $9.2M 13k 737.56

More positions owned by Stempoint Capital

Abivax Sa Sponsored Ads (ABVX)
Scholar Rock Hldg Corp (SRRK)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Syndax Pharmaceuticals (SNDX)
Structure Therapeutics Sponsored Ads (GPCR)
Arcellx Common Stock (ACLX)
Roivant Sciences SHS (ROIV)
Terns Pharmaceuticals (TERN)
Twist Bioscience Corp (TWST)
Immunovant (IMVT)
Dyne Therapeutics (DYN)
Xenon Pharmaceuticals (XENE)
Surrozen Com New (SRZN)
Celcuity (CELC)
Mineralys Therapeutics (MLYS)

View all positions for Stempoint Capital

Top funds holding Argenx Se

FMR
Henderson Group
Capital World Investors
Artisan Partners Limited Partnership
venBio Select Advisor
Citadel Advisors
BlackRock
Wellington Management Company
Rtw Investments
ClearBridge Advisors
Bellevue Group
Invesco
Sands Capital Management
Millennium Management
Sei Investments

View all funds holding Argenx Se